Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
genetic toxicity in vitro, other
Remarks:
Type of genotoxicity: other: Various in vitro methods are reviewed
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
Not applicable
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
The EU RAR summarises a very large number of genotoxicity studies of varying quality and largely performed to non-standard designs. However the consistently positive responses mean that the studies taken as a whole are reliable. The RAR also covers studies discussed in earlier reviews by the UK HSE (1989) and the UK IOH (1997).

Data source

Reference
Reference Type:
other: EU RAR
Title:
European Union Risk Assessment Report: chromium trioxide, sodium chromate, sodium dichromate, ammonium dichromate, potassium dichromate
Author:
European Chemicals Bureau
Year:
2005
Bibliographic source:
3rd Priority List; Volume 53

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
The EU RAR summarises the results of a large number of studies in vitro performed using chromium (VI) compounds, to various (and largely non-standard) protocols.
GLP compliance:
not specified
Remarks:
Mainly published studies
Type of assay:
other: Various in vitro methods are reviewed

Test material

Constituent 1
Reference substance name:
Chromium trioxide
EC Number:
215-607-8
EC Name:
Chromium trioxide
Cas Number:
1333-82-0
IUPAC Name:
1333-82-0
Constituent 2
Chemical structure
Reference substance name:
Sodium chromate
EC Number:
231-889-5
EC Name:
Sodium chromate
Cas Number:
7775-11-3
Molecular formula:
CrH2O4.2Na
IUPAC Name:
disodium dioxido(dioxo)chromium
Constituent 3
Chemical structure
Reference substance name:
Sodium dichromate
EC Number:
234-190-3
EC Name:
Sodium dichromate
Cas Number:
10588-01-9
Molecular formula:
Cr2Na2O7
IUPAC Name:
sodium dichromate
Constituent 4
Chemical structure
Reference substance name:
Potassium dichromate
EC Number:
231-906-6
EC Name:
Potassium dichromate
Cas Number:
7778-50-9
Molecular formula:
Cr2H2O7.2K
IUPAC Name:
sodium dichromate
Details on test material:
No further details

Method

Target gene:
Various
Species / strain
Species / strain / cell type:
other: various
Metabolic activation:
with and without
Test concentrations with justification for top dose:
Various
Controls
Untreated negative controls:
not specified
Negative solvent / vehicle controls:
not specified
True negative controls:
not specified
Positive controls:
not specified
Positive control substance:
not specified
Details on test system and experimental conditions:
Not reported for individual studies
Evaluation criteria:
Not reported for individual studies
Statistics:
Not reported for individual studies

Results and discussion

Test results
Species / strain:
other: various
Metabolic activation:
with and without
Genotoxicity:
positive
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
not specified
Untreated negative controls validity:
not specified
Positive controls validity:
not specified
Additional information on results:
The results of a very large number of studies performed in vitro with the water-soluble hexavlent chromium compounds are largely positive.
Remarks on result:
other: all strains/cell types tested

Any other information on results incl. tables

The results of a very large number of studies performed in vitro with the water-soluble hexavlent chromium compounds are largely positive.

The EU RAR therefore concludes that there is a very large body of evidence indicating that the Cr (VI) ion in solution is directly mutagenic in in vitro systems; this conclusion is relevant to all compounds in this group.

Applicant's summary and conclusion

Conclusions:
Interpretation of the results:
positive weight of evidence approach

The weight of evidence in various test systems indicates that water soluble Cr (VI) compounds in this group are genotoxic in vitro.
Executive summary:

The EU RAR summarises the results of a number of in vitro studies of various designs and reliability performed over a number of years. The RAR itself also takes into account the findings of the earlier reviews of the toxicity of Cr (VI) compounds by the UK Health & Safety Executive (HSE, 1989) and the UK Institute of Health (IOH, 1997), which came to similar conclusions. It is concluded that water soluble Cr (VI) compounds are genotoxic in vitro.